Ionis Pharmaceuticals Ownership | Who Owns Ionis Pharmaceuticals?
Ionis Pharmaceuticals Ownership Summary
Ionis Pharmaceuticals is owned by 57.60% institutional investors, 0.72% insiders, and 41.69% retail investors. Dld asset management, lp is the largest institutional shareholder, holding 15.71% of IONS shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 6.84% of its assets in Ionis Pharmaceuticals shares.
IONS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Ionis Pharmaceuticals | 57.60% | 0.72% | 41.69% |
| Sector | Healthcare Stocks | 232.52% | 10.72% | -143.24% |
| Industry | Biotech Stocks | 384.56% | 10.59% | -295.14% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Dld asset management, lp | 25.00M | 15.71% | $34.63B |
| Fmr | 23.69M | 14.89% | $1.55B |
| Capital world investors | 17.96M | 11.17% | $1.42B |
| Vanguard group | 16.44M | 10.23% | $1.30B |
| T. rowe price investment management | 13.16M | 8.27% | $860.73M |
| Blackrock | 10.32M | 7.09% | $491.90M |
| Blackrock funding, inc. /de | 10.65M | 6.62% | $842.35M |
| Wellington management group llp | 6.59M | 4.14% | $431.04M |
| Lombard odier asset management (europe) | 6.49M | 4.08% | $8.96M |
| Bellevue group | 6.24M | 3.92% | $408.51M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tweedy, browne | 2.46M | 15.74% | $195.00M |
| Boone capital management | 417.83K | 8.96% | $27.33M |
| Bellevue group | 6.24M | 8.49% | $408.51M |
| Deep track capital, lp | 3.81M | 6.95% | $249.13M |
| Orion investment | 225.16K | 5.43% | $17.81M |
| Exome asset management | 131.02K | 5.19% | $8.57M |
| Privium fund management b.v. | 240.82K | 3.51% | $19.05M |
| Sicart associates | 163.56K | 3.43% | $12.94M |
| Sector gamma as | 184.98K | 3.34% | $14.63M |
| Vestal point capital, lp | 1.07M | 3.18% | $70.33M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Dld asset management, lp | 25.00M | 2.48% | 25.00M |
| Lombard odier asset management (europe) | 6.49M | 0.45% | 6.49M |
| Capital world investors | 17.96M | 0.19% | 5.24M |
| Deerfield management company, l.p. (series c) | 1.98M | 1.98% | 1.98M |
| Jpmorgan chase | 2.30M | 0.01% | 1.76M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| T. rowe price investment management | 13.16M | 0.53% | -2.89M |
| Orbimed advisors | - | - | -2.54M |
| Adage capital partners gp | 1.31M | 0.14% | -2.48M |
| Bvf inc/il | - | - | -1.91M |
| Bellevue group | 6.24M | 8.49% | -1.61M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Dld asset management, lp | 25.00M | 2.48% | 25.00M | $34.63B |
| Lombard odier asset management (europe) | 6.49M | 0.45% | 6.49M | $8.96M |
| Deerfield management company, l.p. (series c) | 1.98M | 1.98% | 1.98M | $129.51M |
| Balyasny asset management | 768.65K | 0.05% | 768.65K | $30.37M |
| Summit partners public asset management | 750.00K | 1.02% | 750.00K | $49.06M |
Sold Out
| Holder | Change |
|---|---|
| Mv capital management | -3.00 |
| Wealthtrak capital management | -5.00 |
| Bryn mawr trust | -5.00 |
| Hexagon capital partners | -9.00 |
| Ronald blue trust | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 388 | -18.32% | 92,594,267 | -53.74% | 57 | 0.36% | 211 | -18.53% | 100 | -14.53% |
| Sep 30, 2025 | 449 | 17.23% | 194,303,017 | 14.72% | 122 | 1.08% | 241 | 17.56% | 115 | 6.48% |
| Jun 30, 2025 | 379 | 3.55% | 169,594,655 | 1.94% | 106 | 0.97% | 201 | 28.85% | 108 | -14.29% |
| Mar 31, 2025 | 15 | -96.08% | 14,001,670 | -91.30% | 8 | 0.08% | 6 | -96.65% | 6 | -94.92% |
| Dec 31, 2024 | 235 | -38.48% | 100,254,792 | -35.75% | 67 | 0.61% | 111 | -39.34% | 73 | -31.78% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 10.91M | 6.84% | 14.25K |
| Fidelity Growth Compy Commingled Pl O | 9.71M | 6.16% | 90.97K |
| BB Biotech AG Ord | 7.85M | 4.97% | - |
| Fidelity Growth Company Fund | 7.70M | 4.83% | -46.11K |
| T. Rowe Price US Mid-Cap Growth Equity | 5.99M | 3.77% | 300.20K |
| T. Rowe Price Mid-Cap Growth | 5.98M | 3.75% | -11.00K |
| Vanguard Total Stock Mkt Idx Inv | 4.77M | 2.99% | -99.81K |
| American Funds SMALLCAP World A | 4.57M | 2.87% | 108.08K |
| Vanguard US Total Market Shares ETF | 4.50M | 2.83% | 256.36K |
| Vanguard Health Care Inv | 3.99M | 2.50% | -1.74M |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 13, 2026 | Swayze Eric | EVP Research | Sell | $769.51K |
| Feb 13, 2026 | Swayze Eric | EVP Research | Sell | $509.40K |
| Feb 11, 2026 | PARSHALL B LYNNE | - | Sell | $413.59K |
| Feb 06, 2026 | Monia Brett P | Chief Executive Officer | Sell | $2.52M |
| Feb 02, 2026 | BENNETT C FRANK | EVP, Chief Scientific Officer | Sell | $1.65M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 32 |
| 2025 Q4 | - | 33 |
| 2025 Q3 | - | 40 |
| 2025 Q2 | 1 | 3 |
| 2025 Q1 | - | 23 |
IONS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools